[go: up one dir, main page]

ES553851A0 - Procedimiento para preparar derivados de nitrofurano - Google Patents

Procedimiento para preparar derivados de nitrofurano

Info

Publication number
ES553851A0
ES553851A0 ES553851A ES553851A ES553851A0 ES 553851 A0 ES553851 A0 ES 553851A0 ES 553851 A ES553851 A ES 553851A ES 553851 A ES553851 A ES 553851A ES 553851 A0 ES553851 A0 ES 553851A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
nitrofuran derivatives
nitrofuran
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553851A
Other languages
English (en)
Other versions
ES8703456A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of ES553851A0 publication Critical patent/ES553851A0/es
Publication of ES8703456A1 publication Critical patent/ES8703456A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES553851A 1985-04-11 1986-04-10 Procedimiento para preparar derivados de nitrofurano Expired ES8703456A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8505424A FR2580281B1 (fr) 1985-04-11 1985-04-11 Derives du nitrofuranne, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES553851A0 true ES553851A0 (es) 1987-02-16
ES8703456A1 ES8703456A1 (es) 1987-02-16

Family

ID=9318115

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553851A Expired ES8703456A1 (es) 1985-04-11 1986-04-10 Procedimiento para preparar derivados de nitrofurano

Country Status (18)

Country Link
US (1) US4711892A (es)
EP (1) EP0200605A1 (es)
JP (1) JPS61236776A (es)
KR (1) KR860008168A (es)
CN (1) CN86102565A (es)
AU (1) AU5591486A (es)
DK (1) DK161086A (es)
ES (1) ES8703456A1 (es)
FI (1) FI861526L (es)
FR (1) FR2580281B1 (es)
GR (1) GR860950B (es)
HU (1) HUT43592A (es)
IL (1) IL78357A0 (es)
MA (1) MA20660A1 (es)
NO (1) NO861240L (es)
PT (1) PT82364B (es)
TN (1) TNSN86054A1 (es)
ZA (1) ZA862708B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006127A1 (en) * 1986-04-07 1987-10-22 The Upjohn Company Anthelmintic acylhydrazones, method of use and compositions
US4820718A (en) * 1987-09-17 1989-04-11 Sandoz Pharm. Corp. N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furanyl)-substituted cyclimmonium salts and use thereof in PAF inhibition
GB9615944D0 (en) * 1996-07-30 1996-09-11 Kodak Ltd A material,method and apparatus for inhibiting microbial growth in an aqueous medium
US7629002B2 (en) * 2000-02-16 2009-12-08 Chemeq Ltd. Antimicrobial polymeric compositions and method of treatment using them
EP1296688A2 (en) * 2000-03-23 2003-04-02 Influx, Inc. Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide, oxy amide or 8-hydroxy quinoline structure
DK1689795T3 (da) * 2003-11-06 2010-06-28 Chemeq Ltd Fremgangsmåde til fremstilling af polyakrolein
CN107417673B (zh) * 2017-04-25 2019-10-01 西华大学 N-(2-吡啶基)亚甲基-2-氰基-3-杂环基丙烯酰肼类衍生物及其应用
CN108558858A (zh) * 2018-05-23 2018-09-21 成都师范学院 硝基呋喃类抗结核化合物
CN110642743B (zh) * 2019-10-18 2021-01-01 中国农业大学 硝呋酚酰肼半抗原和人工抗原及其制备方法与应用
CN114225095A (zh) * 2021-12-10 2022-03-25 中国科学技术大学 生物基抗菌复合粘合材料及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703322A (en) * 1951-03-17 1955-03-01 Hoffmann La Roche Derivatives of isonicotinyl hydrazine
US2874189A (en) * 1957-03-28 1959-02-17 Nat Drug Co Pharmaceuticals
US3072726A (en) * 1959-08-24 1963-01-08 Hoffmann La Roche N1-cycloalkanoyl and n1-[alpha-tri-alkyl]-alkanoyl-hydrazides and derivatives thereof

Also Published As

Publication number Publication date
FR2580281A1 (fr) 1986-10-17
US4711892A (en) 1987-12-08
DK161086D0 (da) 1986-04-10
KR860008168A (ko) 1986-11-12
FI861526A7 (fi) 1986-10-12
NO861240L (no) 1986-10-13
AU5591486A (en) 1986-10-16
CN86102565A (zh) 1986-11-12
FI861526A0 (fi) 1986-04-10
ZA862708B (en) 1986-11-26
EP0200605A1 (fr) 1986-11-05
PT82364A (fr) 1986-05-01
DK161086A (da) 1986-10-12
PT82364B (fr) 1988-03-18
MA20660A1 (fr) 1986-12-31
IL78357A0 (en) 1986-07-31
ES8703456A1 (es) 1987-02-16
JPS61236776A (ja) 1986-10-22
HUT43592A (en) 1987-11-30
FI861526L (fi) 1986-10-12
GR860950B (en) 1986-08-06
FR2580281B1 (fr) 1987-09-18
TNSN86054A1 (fr) 1990-01-01

Similar Documents

Publication Publication Date Title
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES548921A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES555048A0 (es) Procedimiento para la obtencion de derivados de azolilmetil-ciclopropilcarbinol sustituido
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
MX164766B (es) Procedimiento para la obtencion de derivados de cefem
ES557691A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES553067A0 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
ES539717A0 (es) Procedimiento para preparar derivados azolilalquilicos
ES553851A0 (es) Procedimiento para preparar derivados de nitrofurano
ES551733A0 (es) Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol
ES551410A0 (es) Procedimiento de preparar derivados rodaninicos.
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES542469A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
ES557596A0 (es) Procedimiento para la obtencion de derivados de hexosa acilados
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
ES547090A0 (es) Procedimiento para preparar derivados de benzazol
ES554828A0 (es) Procedimiento para preparar derivados de fluoralcanos.
ES557598A0 (es) Procedimiento para la obtencion de derivados de hexosa acilados
ES557171A0 (es) Procedimiento para preparar derivados de isoquinolinona
ES551777A0 (es) Procedimiento de preparacion de derivados de 3-hidroxi-3-fenilpiperidina
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina